|
 |
| CNS/mets |
|
Knisely, J., Berkey, B., Chakravarti, A., Yung, W. A., Curran, W., Robins, H. I., Movsas, B., Brachman, D., Henderson, R. and Mehta, M.: RTOG 0118: A Phase III Study of Conventional Radiation Therapy Alone vs. Conventional Radiation Therapy Plus Thalidomide for Multiple Brain Metastases. Proc Am Soc Clin Oncol (ASCO), Orlando, FL, J Clin Oncol, [23] (16S) pg. 114s, Abs. #1500, 2005. |
0118 |
chemo |
 |
| CNS/brain |
|
Cardinale, R. M., Won, M., Choucair, A., Gillin, M., Chakravarti, A., Schultz, C., Souhami, L., Chen, A., Pham, H. T. and Mehta, M.: A Phase II Trial of Accelerated Radiotherapy Using Weekly Stereotactic Conformal Boosts for Supratentorial Glioblastoma Multiforme. RTOG-0023. Proc Am Soc Clin Oncol (ASCO), Orlando, FL, J Clin Oncol, [23S] (16S) pg. 116s, Abs. #1511, 2005. |
0023 |
SRS |
|
| CNS/brain |
|
Vogelbaum, M., Berkey, B., Peereboom, D., Giannini, C., Suh, J., Brown, P. D., Blumenthal, D., Biggs, C., Schultz, C. and Mehta, M.: RTOG 0131: Phase II Trial of Pre-Irradiation and Concurrent Temozolomide in Patients with Newly Diagnosed Anaplastic Oligodendrogliomas and Mixed Anaplastic Oligodendrogliomas. Proc Am Soc Clin Oncol (ASCO), Orlando, FL, J Clin Oncol, [23] (16S) pg. 119s, Abs. #1520, 2005. |
0131 |
chemo |
|
| CNS/brain |
|
Shaw, E., Won, M., Brachman, D., Schultz, C., Suh, J., Buckner, J. C., Barger, G., Coons, S., Bullard, D. and Mehta, M.: Preliminary Results of RTOG Protocol 9802: A Phase II Study of Observation in Completely Resected Adult Low-Grade Glioma. World Federation of NeuroOncology (EANO), Edinburgh, United Kingdom, EANO VI Meeting Booklet, pg. Abs. 2005. |
9802 |
|
|
| CNS/brain |
|
Fox, S., Berkey, B., Michalski, J., Purdy, J., Simpson, J., Kresl, J. J., Curran Jr, W., Diaz, A., Mehta, M. and Movsas, B.: Health-Related Quality of Life and Cognitive Status in Patients with Glioblastoma Multiforme Receiving Escalating Doses of Conformal Three-Dimensional Radiation on RTOG 9803. Proc Amer Soc Thera Rad Onc (ASTRO), Denver, CO, Int J Radiat Oncol Biol Phys, [63] (Suppl. 1) pg. S78, Abs. #128, 2005. |
9803 |
QOL |
|
| CNS/brain |
|
Chakravarti, A., Seiferheld, W., Tu, X., Wang, H., Zhang, H. Z., Ang, K. K., Hammond, E., Curran Jr, W. and Mehta, M.: Immunohistochemically Determined Total Epidermal Growth Factor Receptor Levels Not of Prognostic Value in Newly Diagnosed Glioblastoma Multiforme: Report from The Radiation Therapy Oncology Group. Int J Radiat Onco Biol Phys, 62 (2):318-327, 2005. |
multi |
EGFR/path |
|
| CNS/brain |
|
Lustig, R., Scott, C. and Curran Jr, W.: Does Stereotactic Eligibility for the Treatment of Glioblastoma Cause Selection Bias in Randomized Studies? Am J Clin Oncol, 27 (5):516-521, 2004. |
9006 |
chemo/td |
|
| CNS/brain |
9305 |
Souhami, L., Seiferheld, W., Brachman, D., Podgorsak, E., Werner-Wasik, M., Lustig, R., Schultz, C., Sause, W., Okunieff, P., Buckner, J., Zamorano, L., Mehta, M. and Curran Jr, W.: Randomized Comparison of Stereotactic Radiosurgery Followed by Conventional Radiotherapy with Carmustine to Conventional Radiotherapy with Carmustine for Patients with Glioblastoma Multiforme: Report of Radiation Therapy Oncology Group 93-05 Protocol. Int J Radiat Onco Biol Phys, 60 (3):853-860, 2004. |
9305 |
SRS |
|
| CNS/brain |
|
Berk, L., Seiferheld, W., Rich, T., Hrushesky, W., Blask, D., Gallagher, M., Kudrimoti, M., McGarry, R., Suh, J. and Mehta, M.: RTOG BR-0119: Chronobiological Study of the Addition of Melatonin to Radiotherapy for Brain Metastases. Proc from Soc for Neuro-Oncology (SNO), Toronto, CANADA, Neuro-Oncol, [6] (4) pg. 308-387, Abs. #RT-01, 2004. |
0119 |
chemo |
|
| CNS/brain |
|
Cairncross, G., Seiferheld, W., Shaw, E., Jenkins, R., Scheithauer, B., Brachman, D., Buckner, J., Fink, K., Souhami, L. and Curran Jr, W.: An Intergroup Randomized Controlled Clinical Trial (RCT) of Chemotherapy plus Radiotherapy (RT) versus RT alone for Pure and Mixed Anaplastic Oligodendroglioma: Initial Report of RTOG 94-02. Proc from Soc for Neuro-Oncology (SNO), Toronto, CANADA, Neuro-Oncol, [6] (4) pg. 308-387, Abs. #TA-09, 2004. |
9402 |
oligo
path/chemo |
|
| CNS/brain |
|
Robins, H., Won, M., Seiferheld, W., Schultz, C., Choucair, A., Brachman, D., Demas, W. and Mehta, M.: A Phase II Trial of Conventional Radiation Therapy (XRT) Plus High Dose Tamoxifen (TAM) for the Treatment of Supratentorial Glioblastoma Multiforme (GBM): RTOG Protocol BR-0021. Proc from Soc for Neuro-Oncology (SNO), Toronto, CANADA, Neuro-Oncol, [6] (4) pg. 363, Abs. #RT-19, 2004. |
0021 |
chemo |
|
| CNS/mets |
9508 |
Andrews, D., Scott, C., Sperduto, P., Flanders, A., Gaspar, L., Schell, M., Werner-Wasik, M., Demas, W., Ryu, J., Bahary, J.-P., Souhami, L., Rotman, M., Mehta, M. and Curran Jr, W.: Whole Brain Radiation Therapy With Or Without Stereotactic Radiosurgery Boost for Patients With One to Three Brain Metastases: Phase III Results of the RTOG 9508 Randomised Trial. Lancet, 363 (9422):1665-1672, 2004. |
9508 |
SRS |
|
| CNS/brain |
|
Chang, S., Seiferheld, W., Curran Jr, W., Share, R., Atkins, J., Choucair, A., Kresl, J., Thoron, L., Cairncross, J. G., Gilbert, M., Bahary, J.-P., Dolinskas, C., Louis, D., Bushurnow, P., Buckner, J., Barger, G. and Mehta, M.: Phase I Study Pilot Arms of Radiotherapy and Carmustine with Temozolomide for Anaplastic Astrocytoma (Radiation Therapy Oncology Group 9813): Implications for Studies Testing Initial Treatment of Brain Tumors. Int J Radiat Onco Biol Phys, 59 (4):1122-1126, 2004. |
9813 |
chemo |
|
| CNS/brain |
|
Shaw, E., Seiferheld, W., Cairncross, G., Jenkins, R., Scheithauer, B., Brachman, D., Buckner, J., Fink, K., Souhami, L. and Curran Jr, W.: Radiation Therapy (RT) Alone vs Intensive Procarbazine-CCNU-Vincristine (I-PCV) Chemotherapy Followed by Radiation Therapy for Anaplastic Oligodendroglioma (AO) and Mixed Oligo-Astrocytoma (MOA): Results of Radiation Therapy Oncology Group (RTOG) - Intergroup Protocol 94-02. Proc Amer Soc Thera Rad Onc (ASTRO), Atlanta, GA, Int J Radiat Oncol Biol Phys, [60] (1) pg. S163, Abs. #57, 2004. |
9402 |
oligo
path/chemo |
|
| CNS/brain |
|
Werner-Wasik, M., Seiferheld, W., Michalski, J., Gilbert, M., Purdy, J., Simpson, J., Kresl, J. J., Curran Jr, W., Diaz, A. and Mehta, M.: Phase I/II Conformal Three-Dimensional Radiation Therapy Dose Escalation Study in Patients with Supratentorial Glioblastoma Multiforme: Report of the Radiation Therapy Oncology Group 98-03 Protocol. Proc Amer Soc Thera Rad Onc (ASTRO), Atlanta, GA, Int J Radiat Oncol Biol Phys, [60] (1) pg. S163-164, Abs. #58, 2004. |
9803 |
RT/3D |
|
| CNS/brain |
|
Quang, T. S. and Brady, L.: Radioimmunotherapy as a Novel Treatment Regimen: 125I-Labeled Monoclonal Antibody 425 in the Treatment of High-Grade Brain Gliomas. Int J Radiat Onco Biol Phys, 58 (3):972-975, 2004. |
|
EGFR/GBM |
|
| CNS/brain |
|
Brown, P., Buckner, J., O'Fallon, J., Iturria, N., Brown, C., O'Neill, B., Scheithauer, B., Dinapoli, R., Arusell, R., Curran Jr, W., Abrams, R. and Shaw, E.: Effects of Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma Measured by the Folstein Mini-Mental State Examination. J Clin Oncol, 21 (13):2519-2524, 2003. |
9110 |
|
|
| CNS/brain |
|
Brown, P., Buckner, J., O'Fallon, J., Iturria, N., O'Neill, B., Brown, C., Scheithauer, B., Dinapoli, R., Arusell, R., Curran Jr, W., Abrams, R. and Shaw, E.: Importance of Baseline Mini-Mental State Examination as a Prognostic Factor for Patients with Low-Grade Glioma. Int J Radiat Onco Biol Phys, 59 (1):117-125, 2004. |
9110 |
|
|
| CNS/brain |
|
Robins, H., Won, M., Schultz, C., Choucair, A., Brachman, D., Demas, W. and Mehta, M.: A Phase II Trial of Conventional Radiation Therapy (XRT) Plus High Dose Tamoxifen (TAM) for the Treatment of Supratentorial Glioblastoma Multiforme (GBM): RTOG Protocol BR-0021. Proc Am Soc Clin Oncol (ASCO), New Orleans, LA, J Clin Oncol, [23] (June 5-8, 2004) pg. 114, Abs. #1529, 2004. |
0021 |
chemo |
|
| CNS/brain |
|
Cairncross, G., Seiferheld, W., Shaw, E., Jenkins, R., Scheithauer, B., Brachman, D., Buckner, J., Fink, K., Souhami, L. and Curran Jr, W.: An Intergroup Randomized Controlled Clinical Trial (RCT) of Chemotherapy plus Radiation (RT) versus RT alone for Pure and Mixed Anaplastic Oligodendrogliomas: Initial Report of RTOG 94-02. Proc Am Soc Clin Oncol (ASCO), New Orleans, LA, J Clin Oncol, [23] (June 5-8, 2004) pg. 107, Abs. #1500, 2004. |
9402 |
oligo
path/chemo |
|
| CNS/brain |
|
Regine, W., Schmitt, F., Scott, C., Dearth, C., Patchell, R., Nichols Jr., R., Gore, E., Franklin III, R., Suh, J. and Mehta, M.: Feasibility of Neurocognitive Outcome Evaluations in Patients with Brain Metastases in a Multi-Institutional Cooperative Group Setting: Results of Radiation Therapy Oncology Group Trial BR-0018. Int J Radiat Onco Biol Phys, 58 (5):1346-1352, 2004. |
0018 |
QOL |
|
| CNS/brain |
|
Prados, M., Seiferheld, W., Sandler, H., Buckner, J., Phillips , T., Schultz, C., Urtasun, R., Davis, R., Gutin, P., Cascino, T., Greenberg, H. and Curran Jr, W.: Phase III Randomized Study of Radiotherapy plus Procarbazine, Lomustine, and Vincristine with or without BUdR for Treatment of Anaplastic Astrocytoma: Final Report of RTOG 94-04. Int J Radiat Onco Biol Phys, 58 (4):1147-1152, 2004. |
9404 |
chemo |
|
| CNS/brain |
|
Brat, D., Seiferheld, W., Perry, A., Hammond, E., Murray, K., Schulsinger, A., Mehta, M. and Curran Jr, W.: Analysis of 1p, 19q, 9p, and 10q as Prognostic Markers for High-Grade Astrocytomas Using Fluorescence in situ hybridization on Tissue Microarrays from Radiation Therapy Oncology Group trials. Neuro-Oncol, 6 (2):96-103, 2004. |
multi |
GBM
path |
|
| CNS/brain |
|
Choucair, A., Seiferheld, W., Ford, C., Hansen, J., Dabbas, B., Schultz, C., Schulsinger, A., Mehta, M. and Curran Jr, W.: Long Term Survivors with Glioblastoma Multiforme (GBM) Treated on RTOG Protocols with Irradiation and Nitrosurea Have Higher Initial Expression of Ki-67. Proc Am Soc Clin Oncol (ASCO), New Orleans, LA, J Clin Oncol, [23] (June 5-8, 2004) pg. 871, Abs. #9661, 2004. |
multi |
Ki67/GBM
path |
|
| CNS/brain |
|
Chakravarti, A., Seiferheld, W., Robins, H., Guha, A., Brachman, D., Curran Jr, W., Choucair, A. and Mehta, M.: An Update of Phase I Data from RTOG 0211: A Phase I/II Clinical Study of Gefitinib + Radiation for Newly-Diagnosed Glioblastoma (GBM) Patients. Proc Am Soc Clin Oncol (ASCO), New Orleans, LA, J Clin Oncol, [23] (June 5-8, 2004) pg. 124, Abs. #1571, 2004. |
0211 |
EGFR/ZD 1839
chemo |
|
| CNS/brain |
|
Ford, C., Seiferheld, W., Choucair, A., Hansen, J., Dabbas, B., Schultz, C., Schulsinger, A., Mehta, M. and Curran Jr, W.: Evaluation of Expression of DNA Repair Molecules as a Prognostic Factor for Long-Term Survivors with Glioblastoma Multiforme (GBM) Treated on RTOG Protocols with Irradiation and Nitrosoureas. Proc Am Soc Clin Oncol (ASCO), New Orleans, LA, J Clin Oncol, [23] (June 5-8, 2004) pg. 109, Abs. #1509, 2004. |
multi |
GBM/DNA
path |
|
| CNS/brain |
|
Chakravarti, A., Seiferheld, W., Robins, H., Guha, A., Brachman, D., Curran Jr, W., Choucair, A. and Mehta, M.: An Update of Phase I Data from RTOG 0211: A Phase I/II Clinical Study of ZD 1839 (Gefitinib/Iressa) + Radiation for Newly-Diagnosed Glioblastoma (GBM) Patients. Am Assoc for Cancer Res (AACR), Orlando, FL, AACR Proceedings Booklet, [March, 2004] pg. Abs. #LB-333, 2004. |
0211 |
EGFR/ZD 1839
chemo |
|
| CNS/brain |
|
Chakravarti, A., Dicker, A. and Mehta, M.: The Contribution of Epidermal Growth Factor Receptor (EGFR) Signaling Pathway To Radioresistance in Human Gliomas: A Review of Preclinical and Correlative Clinical Data. Int J Radiat Onco Biol Phys, 58 (3):927-931, 2004. |
|
EGFR/GBM |
|
| CNS/brain |
|
Brown, P., Buckner, J., O'Fallon, J., Iturria, N., Brown, C., O'Neill, B., Scheithauer, B., Dinapoli, R., Arusell, R., Abrams, R., Curran Jr, W. and Shaw, E.: Adult Patients with Supratentorial Pilocytic Astrocytomas: A Prospective Multicenter Clinical Trial. Int J Radiat Onco Biol Phys, 58 (4):1153-1160, 2004. |
9110 |
|
|
| CNS/brain |
|
Shaw, E., Seiferheld, W., Scott, C., Coughlin, C., Leibel, S., Curran Jr, W. and Mehta, M.: Reexamining the Radiation Therapy Oncology Group (RTOG) Recursive Partitioning Analysis (RPA) for Glioblastoma Multiforme (GBM) Patients. Proc Am Soc Thera Rad Oncol (ASTRO), Salt Lake City, UT, Int J Radiat Oncol Biol Phys, [57] (2) pg. S135-136, Abs. #20, 2003. |
7401, 7918, 8302, 9006, 9411 |
CNS/brain
stat |
|
| CNS/brain |
|
Brat, D., Seiferheld, W., Perry, A., Hammond, E., Murray, K., Schulsinger, A., Mehta, M. and Curran Jr, W.: FISH Analysis of Genetic Markers of Prognosis for High Grade Astrocyotmas Using Tissue Micro-Arrays from RTOG Clinical Trials. Proc Am Soc Thera Rad Oncol (ASTRO), Salt Lake City, UT, Int J Radiat Oncol Biol Phys, [57] (2) pg. S135, Abs. #19, 2003. |
multi |
CNS/brain
GBM
path |
|
| CNS/brain |
|
Chakravarti, A., Seiferheld, W., Robins, H., Guha, A., Sperduto, P., Choucair, A., Brachman, D. and Mehta, M.: Phase I Results from RTOG BR-0211, A Phase I/II Study of an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI), ZD 1839 (Iressa), with Radiation Therapy in Glioblastoma Multiforme (GBM). Proc Am Soc Thera Rad Oncol (ASTRO), Salt Lake City, UT, Int J Radiat Oncol Biol Phys, [57] (2) pg. s329, Abs. #1113, 2003. |
0211 |
CNS/brain
chemo |
|
| CNS/brain |
|
Brat, D., Seiferheld, W., Perry, A., Hammond, E., Murray, K., Schulsinger, A., Mehta, M. and Curran Jr, W.: Fluorescence In Situ Hybridization Analysis of 1p, 19q, 9p, and 10q as Prognostic Markers for High-Grade Astrocytomas Using Tissue Micro-arrays from RTOG Trials. Proc from Soc for Neuro-Oncology (SNO), Keystone, Colorado, Neuro-Oncol, [5] (4) pg. 324, Abs. #PA-02, 2003. |
multi |
CNS/brain
GBM
path |
|
| CNS/brain |
|
Shaw, E., Seiferheld, W., Scott, C., Coughlin, C., Leibel, S., Curran Jr, W. and Mehta, M.: Ethnic Differences in Survival of Glioblastoma (GBM): A Secondary Analysis of the Radiation Therapy Oncology Group (RTOG) Recursive Partitioning Analysis (RPA) Database. Proc from Soc for Neuro-Oncology (SNO), Keystone, Colorado, Neuro-Oncol, [5] (4) pg. 296-297, Abs. #EP-14, 2003. |
7401, 7918, 8302, 9006, 9411 |
CNS/brain
stat |
|
| CNS/mets |
|
Shaw, E., Scott, C., Suh, J., Kadish, S., Stea, B., Hackman, J., Pearlman, A., Murray, K., Gaspar, L., Mehta, M., Curran, W. and Gerber, M.: RSR 13 Plus Cranial Radiation Therapy in Patients with Brain Metastases: Comparison with the RTOG Recursive Partitioning Analysis Brain Metastases Database. J Clin Oncol, 21 (12):2364-2371, 2003. |
7918, 8528, 8905, 9104 |
CNS/mets
chemmod |
|
| CNS/brain |
|
Milanes-Yearsley, M., Hammond, E., Pajak, T., Cooper, J., Chang, C., Griffin, T., Nelson, D., Laramore, G. and Pilepich, M.: Tissue Micro-Array: A Cost and Time-Effective Method for Correlative Studies by Regional and National Cancer Study Groups. Mod Pathol, Dec.15 (12):1366-1373, 2002. |
|
CNS/brain
path |
|
| CNS/brain |
|
Ford, J., Seiferheld, W., Mehta, M., Phan, S. and Curran Jr, W.: Comparison of Survival of Patients in the Phase I Study of Motexafin Gadolinium (MGd) with Radiation Therapy (RT) for Glioblastoma Multiforme (GBM), with a Matched Cohort of Patients from The RTOG RPA Glioma Database. Proceeding from Am Soc Clin Oncol (ASCO), Chicago, IL, J Clin Oncol, [22] (May 31-June 3, 2003) pg. 106, Abs. #425, 2003. |
multi |
CNS/brain
sens |
|
| CNS/mets |
9508 |
Sperduto, P., Scott, C., Andrews, D., Schell, M., Flanders, A., Werner-Wasik, M., Demas, W., Ryu, J., Gaspar, L., Bahary, J.-P., Souhami, L., Rotman, M. and Curran, W.: Stereotactic Radiosurgery With Whole Brain Radiation Therapy Improves Survival In Patients With Brain Metastases: Report Of Radiation Therapy Oncology Group Phase III Study 95-08. Amer Radium Society (ARS), Houston, TX, Proceedings ARS Booklet, 2003. |
9508 |
CNS/mets
SRS |
|
| CNS/brain |
|
Chang, S., Seiferheld, W., Curran Jr, W., Byardt, R., Atkins, J., Choucair, A., Brachman, D., Thoron, L., Cairncross, J. G., Gilbert, M., Bahary, J.-P., Dolinskas, C., Louis, D., Bushurnow, P., Buckner, J., Barger, G. and Mehta, M.: Results of the Phase I Study Pilot Arm of Radiation Therapy and BCNU and Temozolomide for Anaplastic Astrocytoma (Radiation Therapy Oncology Group-RTOG 9813). Proc from Soc for Neuro-Oncology (SNO), San Diego, CA, Soc for Neuro-Onc Meeting Program, pg. 366, Abs. #211, 2002. |
9813 |
chemo |
|
| CNS/brain |
|
Michalski, J., Winter, K., Arquette, M., Purdy, J. A., Brachman, D., Curran, W., Simpson, J. and Mehta, M.: Preliminary Toxicity Report on RTOG 9803, a Prospective Dose Escalation Trial Using 3D Conformal Radiation Therapy (3DCRT) in Glioblastoma Multiforme. Proc from Soc for Neuro-Oncology (SNO), San Diego, CA, Soc for Neuro-Onc Meeting Program, pg. Abs. #177, 2002. |
9803 |
3D |
|
| CNS/mets |
9508 |
Sperduto, P., Scott, C., Andrews, D., Schell, M., Flanders, A., Werner-Wasik, M., Demas, W., Ryu, J., Gaspar, L., Bahary, J.-P., Souhami, L., Rotman, M. and Curran, W.: RTOG 9508: A Prospective Randomized Trial of Stereotactic Radiosurgery and Whole Brain Radiation Therapy Versus Whole Brain Radiation Therapy Alone in Patients with 1-3 Brain Metastases Patients; Results and Salvage Therapy Analyses. Proc from Soc for Neuro-Oncology (SNO), San Diego, CA, Soc for Neuro-Onc Meeting Program, pg. 359-360, Abs. #188, 2002. |
9508 |
SRS |
|
| CNS/mets |
9508 |
Conference Proceedings Sperduto, P., Scott, C., Andrews, D., Schell, M., Flanders, A., Werner-Wasik, M., Demas, W., Ryu, J., Gaspar, L., Bahary, J.-P., Souhami, L., Rotman, M. and Curran, W.: Stereotactic Radiosurgery With Whole Brain Radiation Therapy Improves Survival In Patients With Brain Metastases: Report Of Radiation Therapy Oncology Group Phase III Study 95-08. RSNA, Chicago, IL, RSNA Meeting Booklet, pg. 30, Abs. #Invited, P., 2002. |
9508 |
SRS |
|
| CNS/primary |
|
DeAngelis, L., Seiferheld, W., Schold, S. C., Fisher, B. and Schultz, C.: Combination Chemotherapy and Radiotherapy for Primary Central Nervous System Lymphoma: Radiation Therapy Oncology Group Study 93-10. J Clin Oncol, 20 (24):4643-4648, 2002. |
9310 |
chemo |
|
| CNS/brain |
9305 |
Souhami, L., Scott, C., Brachman, D., Podgorsak, E., Werner-Wasik, M., Lustig, R., Schultz, C., Sause, W., Okunieff, P., Buckner, J., Zamorano, L., Mehta, M. and Curran Jr, W.: Randomized Prospective Comparison Of Stereotactic Radiosurgery (SRS) Followed By Conventional Radiotherapy (RT) With BCNU To RT With BCNU Alone For Selected Patients With Supratentorial Glioblastoma Multiforme (GBM): Report Of RTOG 93-05 Protocol. Proc Am Soc Thera Rad Oncol (ASTRO), New Orleans, LA, Int J Radiat Oncol Biol Phys, [54] (2) pg. 94-95, Abs. #158, 2002. |
9305 |
SRS |
|
| CNS/brain |
0018 |
Regine, W., Schmitt, F., Scott, C., Dearth, C., Patchell, R., Nichols Jr., R., Gore, E., Franklin III, R., Suh, J. and Mehta, M.: Feasibility of Neurocognitive Outcome Evaluations in Patients with Brain Metastases in a Multi-Institutional Cooperative Group Setting: Results of Radiation Therapy Oncology Group (RTOG) Trial BR-0018. Proc Am Soc Thera Rad Oncol (ASTRO), New Orleans, LA, Int J Radiat Oncol Biol Phys, [54] (2) pg. 49, Abs. #79, 2002. |
0018 |
QOL |
|
| CNS/brain |
9305 |
Seiferheld, W., Chakravarti, A., Ang, K. K., Tu, X., Hammond, E., Curran Jr, W. and Mehta, M.: Overexpression of the Epidermal Growth Factor Receptor (Egfr), as Determined by EGFR Immunostaining on Tissue Microarrays, Fails to Demonstrate Prognostic Value for Patients with Glioblastoma Multiforme: A Report from RTOG 74-01, 79-18, 83-02, 84-09, 90-06, 93-05, 96-02, and 98-06. Proc Am Soc Thera Rad Oncol (ASTRO), New Orleans, LA, Int J Radiat Oncol Biol Phys, [54] (2) pg. 96, Abs. #161, 2002. |
7401, 7918, 8302, 8409, 9006, 9305, 9602, 9806 |
EGFR |
|
| CNS/brain |
9513 |
Fisher, B., Won, M., Macdonald, D., Johnson, D. and Roa, W.: Phase II Study of Topotecan plus Cranial Radiation for Glioblastoma Multiforme: Results of Radiation Therapy Oncology Group RTOG 95-13. Int J Radiat Onco Biol Phys, 53 (4):980-986, 2002. |
9513 |
rt |
|
| CNS/other |
|
Regine, W., Sperduto, P., Scott, C. and Mehta, M.: What is The Appropriate Primary End Point for Clinical Trials for Patients with Brain Metastases? In Response to Drs. Burri and Asher. 2002. |
|
SRS |
|
| CNS/mets |
9508 |
Sperduto, P., Scott, C., Andrews, D., Schell, M., Flanders, A., Werner-Wasik, M., Demas, W., Ryu, J., Gaspar, L., Bahary, J.-P., Souhami, L., Rotman, M. and Curran, W.: Stereotactic Radiosurgery With Whole Brain Radiation Therapy Improves Survival In Patients With Brain Metastases: Report Of Radiation Therapy Oncology Group Phase III Study 95-08. Proc Am Soc Thera Rad Oncol (ASTRO), New Orleans, LA, Int J Radiat Oncol Biol Phys, [54] (2) pg. 3, Abs. #5, P., 2002. |
9508 |
SRS |
|
| CNS/brain |
9513 |
Seiferheld, W., Mehta, M., DelRowe, J., Macdonald, D., Langer, C., Scott, C., Curran, W. and Yung, W. A.: Five Years of Glioblastoma Multiforme (GBM) Phase II Trials At The Radiation Therapy Oncology Group (RTOG). Proceeding from Am Soc Clin Oncol (ASCO), Orlando, FL, J Clin Oncol, 21: pg. 71a, Abs. #281, 2002. |
9417, 9513, 9602, 9710, 9806 |
chemo |
|
| CNS/brain |
|
Glioma Meta-analysis Trialists (GMT), and Curran Jr, W.: Chemotherapy in Adult High-Grade Glioma: A Systematic Review and Meta-Analysis of Individual Patient Data From 12 Randomised Trials. Lancet, 359 (9311):1011-1018, 2002. |
multi studies |
chemo |
|
| CNS/primary |
|
Shaw, E., Arusell, R., Scheithauer, B., O'Fallon, J., O'Neill, B., Dinapoli, R., Nelson, D., Earle, J., Jones, C., Cascino, T., Nichols, D., Ivnik, R., Hellman, R., Curran, W. and Abrams, R.: Prospective Randomized Trial of Low- Versus High-Dose Radiation Therapy in Adults With Supratentorial Low-Grade Glioma: Initial Report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group Study. J Clin Oncol, 20 (9):2267-2276, 2002. |
9110 |
td |
|
| CNS/brain |
|
Jenkins, R., Curran, W., Scott, C. and Cairncross, J. G.: Pilot Evaluation of 1p and 19q Deletions in Anaplastic Oligodendrogliomas Collected by a National Cooperative Cancer Treatment Group. Am J Clin Oncol (CCT), 24(5):506-508, 2001. |
9402 |
other |
|
| CNS/brain |
9513 |
Mehta, M., Seiferheld, W., DelRowe, J., Macdonald, D., Langer, C., Scott, C., Curran, W. and Yung, W. A.: Glioblastoma Multiforme: The Phase II RTOG Experience. Proc from Soc for Neuro-Oncology (SNO), Washington, DC, Soc for Neuro-Onc Meeting Program, 3(October 2001): pg. 350, Abs. #332, 2001. |
9417, 9513 , 9602, 9710, 9806 |
chemo |
|
| CNS/brain |
|
Passe, S., Law, M., Cairncross, J., Curran, W., Scott, C., Mehta, M., Scheithauer, B. and Jenkins, R.: A Pilot Analysis of 1p and 19q Deletions in Anaplastic Oligodendrogliomas and Mixed Oligoastrocytomas from RTOG Trial 94-02. Proc from Soc for Neuro-Oncology (SNO), Washington, DC, Soc for Neuro-Onc Meeting Program, 3(October 2001): pg. Abs. #263, 2001. |
9402 |
path |
|
| CNS/brain |
|
Prados, M., Seiferheld, W., Sandler, H., Buckner, J., Phillips, T., Schultz, C., Urtasun, R., Davis, R., Gutin, P. and Greenberg, H.: RTOG 94-04: a Phase-3 Randomized Study of Radiotherapy plus Procarbazine, CCNU, and Vincristine (PCV) with or without BudR for the Treatment of Anaplastic Astrocytoma. Proc of Am Soc Ther Rad Oncol (ASTRO), San Francisco, CA, Int J Radiat Oncol Biol Phys, 51(3, Suppl 1): pg. 207, Abs. #1062, 2001. |
9404 |
chemo |
|
| CNS/brain |
|
Yung, W. A., Seiferheld, W., Maor, M., Groves, M., Schultz, C., Vermeulin, S. and Nelson, D.: Conventional Radiation Followed by Recombinant Interferon-Beta for Newly Diagnosed Glioblastoma: A RTOG (Radiation Therapy Oncology Group)Phase II Study (RTOG 97-10). Proc of Am Soc Ther Rad Oncol (ASTRO), San Francisco, CA, Int J Radiat Oncol Biol Phys, 51(3, Suppl 1): pg. 206, Abs. #1061, 2001. |
9710 |
chemo |
|
| CNS/mets |
|
Regine, W., Scott, C., Murray, K. and Curran, W.: Neurocognitive Outcome in Brain Metastases Patients Treated with Accelerated-Fractionation vs. Accelerated-Hyperfractionated Radiotherapy: An Analysis from Radiation Therapy Oncology Group Study 91-04. Int J Radiat Onco Biol Phys, 51(3):711-717, 2001. |
9104 |
QOL |
|
| CNS/primary |
|
Fisher, B., Seiferheld, W., Schultz, C., DeAngelis, L., Nelsen, D., Schold, S. and Curran, W.: Secondary Analysis of RTOG 9310: An Intergroup Phase II Combined Modality Treatment of Primary Central Nervous System Lymphoma with Chemotherapy and Hyperfractionated Radiotherapy. Proc of Am Soc Ther Rad Oncol (ASTRO), San Francisco, CA, Int J Radiat Oncol Biol Phys, 51(3, Suppl 1): pg. 166, Abs. #297, 2001. |
9310 |
td |
|
| CNS/primary |
|
Fisher, B., Seiferheld, W., Schultz, C., DeAngelis, L., Nelson, D., Schold, S. and Curran, W.: Secondary Analysis of RTOG 9310: An Intergroup Phase II Combined Modality Treatment of Primary Central Nervous System Lymphoma with Chemotherapy and Hyperfractionated Radiotherapy. Proc from Soc for Neuro-Oncology (SNO), Washington, DC, Soc for Neuro-Onc Meeting Program, 3(October 2001): pg. 348-349, Abs. #325, 2001. |
9310 |
chemo |
|
| CNS/mets |
|
Carde, P., Timmerman, R., Mehta, M., Koprowski, C., Ford, J., Tishler, R., Miles, D., Miller, R. and Renschler, M.: A Multicenter Phase Ib/II Trial of the Radiation Enhancer Motexafin Gadolinum in Patients with Brain Metastases. J Clin Oncol, 19(7):2074-2083, 2001. |
|
sens |
|
| CNS/mets |
|
Sanghavi, S., Miranpuri, S., Chappell, R., Buatti, J., Mabanta, S., Suh, J., Regine, W., Weltman, E., Sneed, P., Goetsch, S., Breneman, J., Sperduto, P., Freedman, W. and Mehta, M.: Radiosurgery for Patients with Brain Metastases: A Multi-Institutional Analysis, Stratified by the RTOG Recursive Partitioning Analysis Method. Int J Radiat Onco Biol Phys, 51(2):426-434, 2001. |
|
SRS |
|
| CNS/primary |
|
Langer, C., Ruffer, J., Rhodes, H., Paulus, R., Murray, K., Movsas, B. and Curran, W.: Phase II Radiation Therapy Oncology Group Trial of Weekly Paclitaxel and Conventional External Beam Radiation Therapy for Supratentorial Glioblastoma Multiforme. Int J Radiat Oncol Biol Phys, 51(1):113-119, 2001. |
9602 |
chemo |
|
| CNS/brain |
|
Milanes-Yearsley, M., Hammond, E. and Pajak, T.: Tissue Micro Arrays in Immuno-Histochemistry: A Practical, Cost-Effective and Time-Effective Research Tool. US/Canadian Pathology, Atlanta, GA, J US & Canadian Acad Path, #1382, 234A, 2001. |
|
path |
|
| CNS/brain |
|
Yung, W.A., Seiferheld, W., Donahue, B., Richards, R., Kerlin, K., Wong, D., Hug, E., Curran Jr, W. and Fine, H.: A RTOG (Radiation Therapy Oncology Group) Phase II Study of Conventional Radiation Therapy Plus Thalidomide Followed by Thalidomide Post XRT for Supratentorial Glioblastoma. Proceeding from Am Soc Clin Oncol (ASCO), San Francisco, CA, J Clin Oncol, 20 #206, 52a, 2001. |
9806 |
chemo |
|
| CNS/brain |
|
Brown, P., Buckner, J., Brown, C., O’Fallon, J., Iturria, N., O’Neill, B., Dinapoli, R., Cascino, T. and Arusell, R.: The Effects of Radiation on Cognitive Function in Patients with Low-Grade Glioma. Proceeding from Am Soc Clin Oncol (ASCO), San Francisco, CA, J Clin Oncol, 20 #229, 58a, 2001. |
9110 |
|
|
| CNS/mets |
9003 |
Owen, J., Grigsby, P., Caldwell, T., Konski, A., Johnson, D., Demas, W., Movsas, B., Jones, C. V. and Wasserman, T.: Can Costs Be Measured And Predicted By Modeling Within A Cooperative Clinical Trials Group? Economic Methodological Pilot Studies of Radiation Therapy Oncology Group (RTOG) Studies 90-03 and 91-04. Int J Radiat Oncol Biol Phys, 49(3):633-639, 2001. |
9003, 9104 |
ECON |
|
| CNS/primary |
|
Fisher, B., Scott, C., Macdonald, D., Coughlin, C. and Curran, W.: Phase I Study of Topotecan Plus Cranial Radiation for Glioblastoma Multiforme: Results of Radiation Therapy Oncology Group Trial 95-07. J Clin Oncol, 19(4):1111-1117, 2001. |
9507 |
chemo |
|
| CNS/primary |
|
Scott, C., Seiferheld, W., Prados, M., Mehta, M. and Curran, W.: Is Time to Tumor Progression (TTP) an Appropriate Endpoint for Clinical Trials in Anaplastic Astrocytomas (AA)? Analysis of Radiation Therapy Oncology Group (RTOG) Study 9404. Proceeding from Am Soc Clin Oncol (ASCO), San Francisco, CA, J Clin Oncol, 20 #200, 51a, 2001. |
9404 |
chemmod |
|
| CNS/brain |
|
Coughlin, C., Scott, C., Langer, C., Coia, L., Curran, W. and Rubin, P.: Phase II, Two-Arm RTOG Trial (94-11) Of Bischloroethyl-Nitrosourea Plus Accelerated Hyperfractionated Radiotherapy (64.0 or 70.4 Gy) Based on Tumor Volume (> 20 Or < 20 Cm2, Respectively) in the Treatment of Newly-Diagnosed Radiosurgery-Ineligible Glioblastoma Multiforme Patients. Int J Radiat Oncol Biol Phys, 48(5):1351-1358, 2000. |
9411 |
td |
|
| CNS/mets |
9508 |
Sperduto, P., Scott, C., Andrews, D., Schell, M., Werner-Wasik, M., Demas, W., Ryu, J., Fontenesi, J., Rotman, M. and Curran, W.: Preliminary Report of RTOG 95-08: A Phase III Trial Comparing Whole Brain Irradiation Alone Versus Whole Brain Irradiation Plus Stereotactic Radiosurgery for Patients with Two or Three Unresected Brain Metastases. Proc of Am Soc Ther Rad Oncol (ASTRO), Boston, MA, Int J Radiat Oncol Biol Phys, [48], pg. 113, Abs. #6, 2000. |
9508 |
SRS |
|
| CNS/mets |
|
Shaw, E., Scott, C., Stea, B., Suh, J., Kadish, S., Hackman, J., Pearlman, A., Gerber, M., Murray, K., Gaspar, L., Mehta, M. and Curran, W.: RSR13 Plus Cranial Radiation Therapy Improves Survival in Patients with Brain Metastases Compared to the RTOG Recursive Partitioning Analysis Brain Metastases Database: Update of a Phase II Trial. Proc of Am Soc Ther Rad Oncol (ASTRO), Boston, MA, Int J Radiat Oncol Biol Phys, [48], pg. 203, Abs. #183, 2000. |
7918, 8528, 8905, 9104 |
|
|
| CNS/mets |
|
Regine, W., Scott, C., Murray, K. and Curran, W.: Neurocognitive Outcome in Brain Metastasis Patients Treated with Accelerated Fractionation (AF) VS. Accelerated Hyperfractionation (AH) Whole Brain Radiotherapy (WBRT): An Analysis from Radiation Therapy Oncology Group (RTOG) Study 91-04. Proc of Am Soc Ther Rad Oncol (ASTRO), Boston, MA, Int J Radiat Oncol Biol Phys, [48], pg. 158-159, Abs. #94, 2000. |
9104 |
QOL |
|
| CNS/mets |
|
Andrews, D. W., Scott, C., Sperduto, P., Schell, M., Werner-Wasik, M., Thoron, L. and Curran Jr., W. J.: Preliminary Analysis of RTOG 95-08: A Phase III Prospective Randomized Trial Comparing Whole Brain Irradiation Alone Versus Whole Brain Irradiation Plus Stereotactic Radiosurgery for Patients with Two or Three Brain Metastases. Congress of Neurological Surgeons, San Antonio, TX, Cong Neuro Surg, pg. Abs. #771, 2000. |
9104 |
SRS |
|
| CNS/brain |
|
Journal Article 1522 Gaspar, L., Scott, C., Murray, K. and Curran, W.: Validation of the RTOG Recursive Partitioning Analysis (RPA) Classification for Brain Metastases. Int J Radiat Oncol Biol Phys, 47(4):1001-1006, 2000. |
9104 |
meth |
|
| CNS/brain |
|
Murray, K. J., Scott, C., Zachariah, B., Michalski, J. M., Demas, W., Vora, N. L., Whitton, A. and Movsas, B.: Importance of the Mini Mental Status Exam in the Treatment of Patients with Brain Metastases: A Report from the Radiation Therapy Oncology Group Protocol 91-04. Int J Radiat Oncol Biol Phys, 48(1):59-64, 2000. |
9104 |
td |
|
| CNS/brain |
|
Shaw, E., Scott, C., Souhami, L., Dinapoli, R., Kline, R., Loeffler, J. and Farnan, N.: Single Dose Radiosurgical Treatment of Recurrent Previously Irradiated Primary Brain Tumors and Brain Metastases: Final Report of RTOG Protocol 90-05. Int J Radiat Oncol Biol Phys, 47(2):291-298, 2000. |
9005 |
|
|
| CNS/brain |
|
DelRowe, J., Scott, C., Werner-Wasik, M., Bahary, J., Curran, W., Urtasun, R. and Fisher, B.: A Single-Arm Open Label Phase II Study of Intravenously Administered Tirapazamine Plus Radiation Therapy for Glioblastoma Multiforme. J Clin Oncol, 18(6):1254-1259, 2000. |
9417 |
|
|
| CNS/brain |
|
Prados, M., Scott, C., Curran, W., Nelson, D., Leibel, S. and Kramer, S.: PCV Chemotherapy in Anaplastic Glioma: A Retrospective Review of Radiation Therapy Oncology Group (RTOG) Protocols Comparing Survival with Carmustine or PCV Adjuvant Chemotherapy. J Clin Oncol, 17(11):3389-3395, 1999. |
7918, 8302, 9006, 9404 |
chemo |
|
| CNS/mets |
|
Shaw, E., Scott, C., Stea, B., Suh, J., Kadish, S., Hackman, J., Pearlman, A., Gerber, M., Murray, K., Gaspar, L., Mehta, M. and Curran, W.: Survival Improvement with RSR13 Plus Cranial Radiation Therapy (RT) in Patients (PTS) with Brain Metastases: Comparison to the Radiation Therapy Oncology Group (RTOG) Recursive Partitioning Analysis (RPA) Brain Metastases Database (BMD). Proc of Am Soc Clin Oncol (ASCO), New Orleans, LA, J Clin Oncol, 19 159a, 2000. |
7918, 8528, 8905, 9104 |
|
|
| CNS/brain |
9003 |
Owen, J., Grigsby, P., Caldwell, T., Konski, A., Johnson, D., Demas, W., Movsas, B., Jones, C. V. and Wasserman, T.: Can Costs Be Measured And Predicted By Modelling Within A Cooperative Clinical Trials Group? Economic Methodological Pilot Studies of Radiation Therapy Oncology Group (RTOG) Studies 90-03 and 91-04. Proc Am Soc Thera Rad Oncol (ASTRO), San Antonio, TX, Int J Radiat Oncol Biol Phys, [45], pg. 225, Abs. #150, 1999. |
9003, 9104 |
ECON |
|
| CNS/brain |
|
Corn, B., Dolinskas, C., Scott, C., Donahue, B., Schultz, C., Nelson, D. and Fisher, B.: Strong Correlation Between Imaging Response and Survival Among Patients with Primary Central Nervous System Lymphoma: A Secondary Analysis of RTOG Studies 83-15 And 88-06. Int J Radiat Oncol Biol Phys, 47(2):299-303, 2000. |
8315, 8806 |
chemo |
|
| CNS/brain |
|
Schultz, C., Scott, C., DeAngelis, L., Nelson, D., Nelson, J., Schold, S. and Curran, W.: Radiation Therapy (RT) Alone Vs. Pre-RT Chemotherapy (CTX) for the Treatment of Primary CNS Lymphoma (PCNSL): Aged Matched Survival Analysis of RTOG 83-15 and RTOG 93-10. Proc of Am Soc Clin Oncol (ASCO), New Orleans, LA, J Clin Oncol, [19], pg. 159a, Abs. #617, 2000. |
8315, 9310 |
chemo |
|
| CNS/primary |
|
Wasserman, T., Scott, C., Shaw, E., Dryznala, R., Cmelak, A., Coleman, N. and Souhami, L.: A Phase II Trial Of The Radiosensitizer: Etanidazole (Sr-2508) With Radiosurgery For The Treatment Of Recurrent Previously Irradiated Primary Brain Tumors Or Brain Metastases (RTOG Protocol #95-02). Proc Am Soc Thera Rad Oncol (ASTRO), San Antonio, TX, Int J Radiat Oncol Biol Phys, [45], pg. 272, Abs. #1029, 1999. |
9502 |
chemmod |
|
| CNS/other |
|
DeAngelis, L., Seiferheld, W., Schold, S., Fisher, B. and Byhardt, R.: Combined Modality Treatment of Primary Central Nervous system Lymphoma (PCNSL): RTOG 93-10. Proc of Am Soc Clin Oncol (ASCO), Atlanta, GA, J Clin Oncol, [18], pg. 140a, Abs. #537, 1999. |
9310 |
chemo |
|
| CNS/mets |
|
Gaspar, L., Scott, C., Murray, K. and Curran, W.: RTOG Recursive Partitioning Analysis (RPA) Classification for Brain Metastases: A Valid Staging System. American Radium Society, Hapuna Beach, Hawaii, ARS Meeting Book, pg. Abs. #20, 1999. |
9104 |
meth |
|
| CNS/mets |
|
Sanghavi, S., Miranpuri, S., Chappell, R., Mabanta, S., Suh, J., Regine, W., Weltman, E., Sneed, P., Goetsch, S., Breneman, J., Sperduto, P., Scott, C., Buatti, J. and MP, M.: Multi-Institutional Survival Analysis of Brain Metastases Patients Treated with Radiosurgery, Stratified by RTOG RPA Classification. Proc Am Soc Thera Rad Oncol (ASTRO), San Antonio, TX, Int J Radiat Oncol Biol Phys, [45], pg. 171, Abs. #48, 1999. |
|
SRS |
|
| CNS/primary |
|
Prados, M., Scott, C., Sandler, H., Buckner, J., Phillips, T., Schultz, C., Urtasun, R., Davis, R., Gutin, P., Cascino, T., Greenberg, H. and Curran, W.: A Phase 3 Randomized Study Of Radiotherapy Plus Procarbazine, CCNU, and Vincristine (PCV) With Or Without Budr For The Treatment Of Anaplastic Astrocytoma: A Preliminary Report Of RTOG 9404. Int J Radiat Oncol Biol Phys, 45(5):1109-1115, 1999. |
9404 |
chemmod |
|
| CNS/mets |
|
Gaspar, L., Scott, C., Murray, K. and Curran, W.: RTOG Recursive Partitioning Analysis (RPA) Classification for Brain Metastases: A Valid Staging System. American Radium Society, Hapuna Beach, Hawaii, ARS Meeting Book, pg. Abs. #20, 1999. |
9104 |
meth |
|
| CNS/brain |
|
Langer, C., Paulus, R., Ruffer, J., Movsas, B., Murray, K., Rhodes, H. and Curran, W.: Phase II RTOG Trial of Weekly Paclitaxel (TAX) and Conventional External Beam Radiation Therapy (EBRT) for Supratentorial Glioblastoma Multiforme (GBM). Proc of Am Soc Clin Oncol (ASCO), Atlanta, GA, J Clin Oncol, [18], pg. 139a, Abs. #534, 1999. |
9602 |
chemo |
|
| CNS/brain |
|
DelRowe, J., Scott, C., Werner-Wasik, M., Bahary, J., Curran, W., Urtasun, R. and Fisher, B.: A Single-Arm Open Label Phase II Study of Intravenously Administered Tirapazamine for Glioblastoma Multiforme (GBM) An RTOG Study. Proc Am Soc Thera Rad Oncol (ASTRO), Phoenix, AZ, Int J Radiat Oncol Biol Phys, [42], pg. 266, Abs. #2077, 1998. |
|
sens |
|
| CNS/brain |
|
Prados, M., Scott, C., Curran, W., Nelson, D., Leibel, S. and Kramer, S.: PCV Chemotherapy in Anaplastic Glioma: A Retrospective Review of Radiation Therapy Oncology Group (RTOG) Protocols Comparing Survival with BCNU or PCV Adjuvant Chemotherapy. Proc Am Soc Thera Rad Oncol (ASTRO), Phoenix, AZ, Int J Radiat Oncol Biol Phys, [42], pg. 197, Abs. #146, 1998. |
|
chemo |
|
| CNS/brain |
|
Ruffer, J., Scott, C., Langer, C., Movsas, B. and Murray, K.: A Phase II Trial of Weekly Paclitaxel and Conventional Radiotherapy for Supratentorial Glioblastoma Multiforme: RTOG 96-02. Proc Am Soc Thera Rad Oncol (ASTRO), Phoenix, AZ, Int J Radiat Oncol Biol Phys, [42], pg. 265, Abs. #2076, 1998. |
|
chemo |
|
| CNS/brain |
|
Shaw, E., Scott, C., Souhami, L., Dinapoli, R., Kline, R., Loeffler, J. and Farnan, N.: Update of Radiation Therapy Oncology Group (RTOG) Protocol 90-05: Single Dose Radiosurgical Treatment of Recurrent Brain Tumors. Proc Am Soc Thera Rad Oncol (ASTRO), Phoenix, AZ, Int J Radiat Oncol Biol Phys, [42], pg. 196, Abs. #143, 1998. |
|
SRS |
|
| CNS/mets |
|
Gaspar, L., Scott, C., Murray, K. and Curran, W.: Validation of the RTOG Recursive Partitioning Analysis (RPA) Classification for Brain Metastases. Proc Am Soc Thera Rad Oncol (ASTRO), Phoenix, AZ, Int J Radiat Oncol Biol Phys, [42], pg. 260, Abs. #2066, 1998. |
|
meth |
|
| CNS/brain/mets |
|
Murray, K., Scott, C., Zachariah, B., Michalski, J., Demas, W., Fu, K., Lukka, H. and Movsas, B.: Importance of the Mini Mental Status Exam (MMSE) in the Treatment of Patients with Brain Metastases: A Report from the Radiation Therapy Oncology Group Protocol 91-04. Proc Am Soc Thera Rad Oncol (ASTRO), Phoenix, AZ, Int J Radiat Oncol Biol Phys, [42], pg. 261, Abs. #2067, 1998. |
|
td |
|
| CNS/brain |
|
Prados, M., Scott, C., Rotman, M., Rubin, P., Murray, K., Sause, W., Asbell, S., Comis, R., Curran, W., Nelson, J., Davis, R., Levin, V., Lamborn, K. and Phillips, T.: Influence of Bromodeoxyuridine Radiosensitization on Malignant Glioma Patient Survival: A Retrospective Comparison of Survival Data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group Trials (RTOG) for Glioblastoma Multiforme and Anaplastic Astrocytoma. Int J Radiat Oncol Biol Phys, 40(3):653-659, 1998. |
|
chemmod |
|
|
|
Scott, C. B., Scarantino, C., Urtasun, R., Movsas, B., Jones, C. U., Simpson, J. R., Fischbach, A. and Curran, W. J.: Validation and Predictive Power of Radiation Therapy Oncology Group (RTOG) Recursive Partitioning Analysis Classes for Malignant Glioma Patients: A Report Using RTOG 90-06. Int J Radiat Oncol Biol Phys, 40(1):51-55, 1998. |
|
stat |
|
|
|
Nelson, J., Scott, C., Constine, L., Fu, K. and Murray, K.: Alzheimer Related Lesions (ARL) and Neural Morbidity in Glioblastoma (GBM) Patients: Data from Radiation Therapy Oncology Group (RTOG) Glioma Trials. US/Canadian Pathology, Boston, MA, Laboratory Invest/Modern Path, [78], pg. 161A, Abs. #942, 1998. 1998 7401, 7611, 7903, 7918, 8007, 8201, 8302, 8409, 9006 |
|
path |
|
|
|
Shaw, E., Arusell, R., Scheithauer, B., O'Fallon, J., O'Neill, B., Dinapoli, R., Nelson, D., Earle, J., Jones, C., Cascino, T., Nichols, D., Ivnik, R., Hellman, R., Curran, W. and Abrams, R.: A Prospecctive Randomized Trial of Low-Versus High-Dose Radiation Therapy in Adults with Supratentorial Low-Grade Glioma: Initial Report of a NCCTG-RTOG-ECOG Study. Proc of Am Soc Clin Oncol (ASCO), Los Angeles, CA, J Clin Oncol, [17], pg. 401a, Abs. #1545, 1998
| |
td |
|
|
|
Scott, C., Curran, W., Yung, W., Scarantino, C., Urtasun, R., Movsas, B., Jones, C., Simpson, J., Fischbach, A., Petito, C. and Nelson, J.: Long Term Results of RTOG 9006: A Randomized Trial of Hyperfractionated Radiotherapy (RT) to 72.0 Gy & Carmustine vs. Standard RT & Carmustine for Malignant Glioma Patients with Emphasis on Anaplastic Astrocytoma (AA) Patients. Proc of Am Soc Clin Oncol (ASCO), Los Angeles, CA, J Clin Oncol, [17], pg. 401a, Abs. #1546, 1998. |
|
td |
|
| CNS/primary/brain |
|
Choucair, A., Scott, C., Movsas, B., Curran, W., Urtasun, R. and Brasacchio, R.: Prognostic Factors in Malignant Astrocytoma (MA) Data from RTOG 91-41. 12th Intl Conf on Brain Tumour, Oxford, United Kingdom, pg. Abs. 1997. |
|
QOL |
|
| CNS/primary/brain |
|
Corn, B., Dolinskas, C., Scott, C., Donahue, B., Schultz, C., Nelson, D. and Fisher, B.: Strong Correlation Between Imaging Response and Survival Among Patients with Primary Central Nervous System Lymphoma: A Secondary Analysis of RTOG Studies 83-15 and 88-06. Proc of the Society for Neuro-Oncology, Charlottesville, VA, NeuroOncology Booklet, pg. Abs. #25, 1997. |
|
td |
|
| CNS/primary/brain |
|
Kolesar, P., Scott, C., Phillips, T., Leibel, S., Swift, P., Asbell, S., Werner-Wasik, M., Wasserman, T., Urtasun, R. and Byhardt, R.: Prognostic Significance of Post Radiation Tumor Response in Brain Metastases Analysis of Radiation Therapy Oncology Group (RTOG) Database. Proc of the Society for Neuro-Oncology, Charlottesville, VA, NeuroOncology Booklet, pg. Abs. #77, 1997. |
|
stat |
|
| CNS/primary/brain |
|
Murray, K., Scott, C., Greenberg, H., Emami, B., Seider, M., Vora, N., Olson, C., Whitton, A., Movsas, B. and Curran, W.: A Randomized Phase III Study of Accelerated Hyperfractionation versus Standard in Patients with Unresected Brain Metastasis: A Report of the Radiation Therapy Oncology Group (RTOG) 91-04. Int J Radiat Oncol Biol Phys, 39(3):571-574, 1997 |
|
td |
|
| CNS/primary/brain |
|
Perry, J. R., DeAngelis, L. M., Schold Jr., S. C., Burger, P. C., Brem, H., Brown, M. T., Curran, W. J., Scott, C. B., Prados, M. D., Kaplan, R. and Cairncross, J. G.: Challenges in the Design and Conduct of Phase III Brain Tumor Therapy Trials. Neurology, 49:912-917, 1997. |
|
|
|
| CNS/primary/brain |
|
Prados, M., Scott, C., Phillips, T., Davis, R., Sandler, H., Buckner, J., Curran, W., Schultz, C. and Urtasun, R.: Phase III Randomized Study of Radiotherapy Plus PCV With or Without BUdR for the Treatment of Anaplastic Astrocytoma: RTOG 94-04. Proc of the Society for Neuro-Oncology, Charlottesville, VA, NeuroOncology Booklet, pg. Abs. #112, 1997. |
|
sens |
|
| CNS/primary/brain |
|
Schultz, C., Whittaker, M., Kolesar, P., Donahue, B., Fisher, B., Nelson, D., Vitale, C. and Hanson, G.: EBV Infection in Immunocompetent Patients with Primary CNS Lymphoma Treated on RTOG 83-15 and 88-06. Proc of the Society for Neuro-Oncology, Charlottesville, VA, NeuroOncology Booklet, pg. Abs. #123, 1997. |
|
path |
|
| CNS/primary/brain |
|
Choucair, A., Scott, C., Urtasun, R., Nelson, D., Mousas, B. and Curran, W.: Quality of Life and Neuropsychological Evaluation for Patients with Malignant Astrocytomas. RTOG 91-14. Int J Radiat Oncol Biol Phys, 38(1):9-20, 1997. |
|
QOL |
|
| CNS/primary/brain |
|
Corn, B., Dolinskas, C., Scott, C., Donahue, B., Schultz, C., Nelson, D. and Fisher, B.: Strong Correlation Between Imaging Response and Survival Among Patients with Primary Central Nervous System Lymphoma: A Secondary Analysis of RTOG Studies 83-15 and 88-06. Proc Am Soc Thera Rad Oncol (ASTRO), Orlando, FL, Int J Radiat Oncol Biol Phys, [39], pg. 325, Abs. #2169, 1997. |
|
td |
|
| CNS/primary/brain |
|
Coughlin, C., Scott, C., Langer, C., Coia, L., Curran, W. and Rubin, P.: Phase II Tumor Volume-Influenced Dose Escalation of Accelerated Hyperfractionated RT to 64.0 & 70.4 Gy with BCNU for Newly Diagnosed Radiosurgery-Ineligible Glioblastoma Multiforme (GBM) Patients (RTOG 94-11). Proc Am Soc Thera Rad Oncol (ASTRO), Orland, FL, Int J Radiat Oncol Biol Phys, [39], pg. 270, Abs. #2060, 1997 |
|
td |
|
| CNS/primary/brain |
|
Donahue, B., Scott, C., Nelson, J., Rotman, M., Murray, K., Nelson, D., Banker, F., Earle, J., Fischbach, J., Asbell, S., Gaspar, L., Markoe, A. and Curran, W.: Influence of an Oligodendroglial Component on the Survival of Patients with Analplastic Astrocytomas: A Report of Radiation Therapy Oncology Group 83-02. Int J Radiat Oncol Biol Phys, 38(5):911-914, 1997. |
|
path |
|
| CNS/primary/brain |
|
Macdonald, D., Kolesar, P., CT, C., Fisher, B. and Curran, W.: A Phase I Study of Topotecan plus Cranial Radiation for Glioblastoma Multiforme: A Report of Radiation Therapy Oncology Group (RTOG) Study 95-07. Proc Am Soc Thera Rad Oncol (ASTRO), Orlando, FL, Int J Radiat Oncol Biol Phys, [39], pg. 271, Abs. #2061, 1997. |
|
chemo |
|
| CNS/primary/brain |
|
Phuphanich, S., Scott, C., Fischbach, A., Langer, C. and Yung, W. A.: All-Trans-Retinoic Acid: A Phase II Radiation Therapy Oncology Group Study (RTOG 91-13) in Patients with Recurrent Malignant Astrocytoma. J Neuro-Oncol, 34:193-200, 1997. |
|
BRM |
|
| CNS/primary/brain |
|
Prados, M., Scott, C., Phillips, T., Davis, R., Sandler, H., Buckner, J., Curran, W., Schultz, C. and Urtasun, R.: Phase III Randomized Study of Radiotherapy Plus PCV With or Without BUdR for the Treatment of Anaplastic Astrocytoma: RTOG 94-04 Interim Report. Proc Am Soc Thera Rad Oncol (ASTRO), Orlando, FL, Int J Radiat Oncol Biol Phys, [39], pg. 138, Abs. #8, 1997. |
|
chemmod |
|
| CNS/primary/brain |
|
Schultz, C., Whittaker, M., Kolesar, P., Donahue, B., Fisher, B., Nelson, D., Vitale, C. and Hanson, G.: Incidence of EBV Infection in Primary CNS Lymphoma Occurring in Immunocompetent Patients Treated on RTOG 83-15 and 88-06. Proc Am Soc Thera Rad Oncol (ASTRO), Orlando, FL, Int J Radiat Oncol Biol Phys, [39], pg. 176, Abs. #83, 1997. |
|
path |
|
| CNS/primary/brain |
|
Scott, C.: Quality-Adjusted Survival Analysis of Malignant Glioma Patients. Control Clin Trials, 18:277-285, 1997. |
|
td |
|
| CNS |
|
Gaspar, L., Scott, C., Rotman, M., Asbell, S., Phillips, T., Wasserman, T., McKenna, W.G. and Byhardt, R.:
Recursive Partitioning Analysis (RPA) of Prognostic Factors in Three Radiation Therapy Oncology Group (RTOG) Brain Metastases
Trials. Int J Radiat Oncol Biol Phys 37 (4):745-751, 1997. |
|
stat/meth |
|
| CNS |
|
DelRowe, J., Scott, C., Bahary, J., Curran, W., Urtasun, R. and Fisher, B.: A Single-Arm, Open Label, Phase II Study of Intravenously Administered Tirapazamine Plus Radiation Therapy for Glioblastoma Multiforme (GBM)-RTOG 94-17. Proceedings of Proc of Am Soc Clin Oncol (ASCO), J Clin Oncol 16 :385a, 1997. |
9417 |
chemmod |
|
| CNS |
|
Urtasun, R., Fulton, D., Cosmatos, D., Lester, S., Silverstein, M., Kinsella, T. and Wasserman, T.:
Phase I-II Study of Iododeoxyuridine (IUdR) and Radiotherapy in the Treatment of Malignant Glioma (RTOG 86-12). Proc Am Soc
Thera Radiol Oncol (ASTRO), San Diego, Int J Radiat Oncol Biol Phys, 24 (1):144, [35], 1992. |
8612 |
sens |
|
| CNS |
|
Scott, C., Choucair, A., Urtasun, R., Nelson, D., Coia, L. and Curran, W.: Mini-Mental Status Exam Versus the
Radiation Therapy Oncology Group's (RTOG) Neurologic Function Status Scale. Cross-Validation Using Patients from RTOG 91-14.
International Society for Quality of Life Research, Montreal,Quebec Canada, Quality of Life Research, 4 (5):483, 1995. |
9114 |
QOL |
|
| CNS |
|
Nelson, J., Petito, C., Scott, C., Nelson, D., Asbell, S. and Gaspar, L.: High Cell Density and Nuclear Pleomorphism
Do Not Predict Shortened Survival in Oligodendroglial Tumors: Report from Radiation Therapy Oncology Group (RTOG) Study 83-02.
Am Assoc Neuropathologist, Vancouver BC, J Neuropathology & Experimental Neurology, 55 (5):638, [134], 1996. |
8302 |
path |
|
| CNS |
|
Schultz, C., Scott, C., Sherman, W., Donahue, B., Fields, J., Murray, K., Fisher, J., Abrams, R. and Meis-Kindblom,
J.: Pre-Irradiation Chemotherapy with Cyclophosphamide, Adriamycin, Vincristine, and Dexamethasone for Primary Central Nervous
System Lymphomas: Initial Report of Radiation Therapy Oncology Group (RTOG) Protocol 88-06. J Clin Oncol, 14(2):556-564, 1996. |
8806 |
chemo |
|
| CNS/brain |
|
Curran, W. J. and Scott, C. B.: Radiosurgery for Glioma Patients: Hope or Hype? Int J Radiat Oncol Biol Phys,
36(5):1279-1280, 1996. |
|
SRS |
|
| CNS/brain |
|
Curran, W. J.: Should Patients with Histologically Unverified Brain Tumors Receive Cranial Irradiation? Int J Radiat Oncol Biol Phys, 28(2):549-550, 1994. |
|
other |
|
| CNS/brain |
|
Simpson, J. R. and Scott, C. B.: Reply to Dr. Warnke. Int J Radiat Oncol Biol Phys, 29(1):220, 1994. |
|
other |
|
| CNS/brain |
|
Urtasun, R., Farnan, N., DelRowe, J., Kinsella, T., Lester, S. and Fulton, D.: Survival Improvement in Anaplastic Astrocytoma, Combining External Radiation with Halogenated Pyrimidines. Final Report of RTOG 86-12, Phase I-II Study. Proc Am Soc Thera Radiol Oncol (ASTRO), Miami Beach, FL, Int J Radiat Oncol Biol Phys, 32 (Supplement 1):206, [130], 1995. |
8612 |
sens |
|
| CNS/brain |
|
Group, R.: Brain Tumor Update From RTOG. Oncol, 8(1):46-48, 1994. |
|
other |
|
| CNS/brain |
|
Curran, W., Scott, C., Shaw, E. and Nelson, J.: Radiation Therapy Oncology Group (RTOG) Clinical Trials for Brain Tumor Patients: Update 1995. Eleventh International Conference on Brain Tumor Research and Therapy, Napa-California, Proceedings Booklet, 1995. |
|
admin |
|
| CNS/brain |
|
Simpson, J. R., Scott, C. B., Rotman, M., Curran, W. J., Constine III, L. S., Fischbach, A. J. and Asbell, S. O.: Race, and Prognosis of Brain Tumor Patients Entering Multicenter Clinical Trials - A Report from the Radiation Therapy Oncology Group. Am J Clin Oncol (CCT), 19(2):114-120, 1996. |
|
specpop |
|
| CNS/brain/mets |
|
Scott, C., Gaspar, L., Rotman, M., Asbell, S., Phillips, T., Wasserman, T., McKenna, W. and Byhardt, R.: Recursive Partitioning Analysis (RPA) of Prognostic Factors in Three Radiation Therapy Oncology Group (RTOG) Brain Metastases Trials. Proc Am Soc Thera Radiol Oncol (ASTRO), Miami Beach, FL, Int J Radiat Oncol Biol Phys, 32 (Supplement 1):132, [132], 1995. |
7916, 8528, 8905 |
stat/meth |
|
| CNS/brain/mets |
|
Shaw, E., Scott, C., Souhami, L., Dinapoli, R., Bahary, J., Kline, R., Wharam, M., Schultz, C., Davey, P., Loeffler, J., DelRowe, J., Marks, L., Fisher, B. and Shin, K.: Radiosurgery for the Treatment of Previously Irradiated Recurrent Primary Brain Tumors and Brain Metastases: Initial Analysis of Radiation Therapy Oncology Group (RTOG) Protocol 90-05. Proc Am Soc Thera Radiol Oncol (ASTRO), San Francisco, Int J Radiat Oncol Biol Phys, 30 (Supplement 1):166, [23], 1994. |
9005 |
SRS |
|
| CNS/mets |
|
Epstein, B., Scott, C., Sause, W., Rotman, M., Sneed, P., Janjan, N., Davis, L., Selim, H., Mohiuddin, M., Wasserman, T. and Curran, W.: Improved Survival Duration in Patients with Unresected Solitary Brain Metastasis Using an Accelerated Hyperfractionated Radiation Therapy at Total Doses of 54.4 Gray and Greater: Results of Radiation Therapy Oncology Group 85-28. Cancer, 71(4):1362-1367, 1993. |
8528 |
td |
|
| CNS/mets |
|
Phillips, T. L., Scott, C. B., Leibel, S. A., Rotman, M. and Weigensberg, I. J.: Results of a Randomized Comparison of Radiotherapy and Bromodeoxyuridine with Radiotherapy Alone for Brain Metastases: Report of RTOG Trial 89-05. Int J Radiat Oncol Biol Phys, 33(2):339-348, 1995. |
8905 |
sens |
|
| CNS/mets |
|
Epstein, B., Scott, C., Sause, W., Rotman, M., Phillips, T., Janjan, N., Davis, L., Selim, H., Mohiuddin, M., Wasserman, T. and Curran, W.: Improved Survival in Patients with Unresected Solitary Brain Metastasis Using Accelerated Hyperfractionated Radiation Therapy (rt) at Total Doses of 54.4 Gy and Greater; Results of RTOG 85-28. Proc Am Soc Thera Radiol Oncol (ASTRO), Int J Radiat Oncol Biol Phys, 21 (1):121, [16], 1991. |
8528 |
td |
|
| CNS/mets |
|
Sause, W. T., Scott, C., Krisch, R., Rotman, M., Sneed, P. K., Janjan, N., Davis, L., Curran, W., Choi, K. N., Selim, H., Mohiuddin, M. and Grigsby, P.: Phase I/II Trial of Accelerated Fractionation in Brain Metastases RTOG 85-28. Int J Radiat Oncol Biol Phys, 26(4):653-657, 1993. |
8528 |
td |
|
| CNS/mets |
|
Swift, P. S., Phillips, T., Martz, K., Wara, W., Mohiuddin, M., Chang, C. H. and Asbell, S. O.: CT Characteristics of Patients with Brain Metastases Treated in RTOG Study 79-16. Int J Radiat Oncol Biol Phys, 25(2):209-214, 1993. |
7916 |
path |
|
| CNS/mets |
|
Murray, K., Scott, C., Greenberg, H., Emami, B., Seider, M., Fu, K., Olson, C., Lukka, H., Movsas, B. and Curran, W.: A Randomized Phase III Study of Accelerated Hyperfractionation versus Standard Fractionation in Patients with Unresected Brain Metastasis: A Report of Radiation Therapy Oncology Group (RTOG) 91-04. Proc Am Soc Thera Radiol Oncol (ASTRO), Los Angeles, CA, Int J Radiat Oncol Biol Phys, 36 (1):193, [69], 1996. |
9104 |
td |
|
| CNS/mets |
|
Komarnicky, L., Phillips, T., Martz, K., Mohiuddin, M., Brady, L., Isaacson, S., Asbell, S. and Urtasun, R.: A Randomized Phase III Protocol for the Evaluation of Misonidazole with Radiation in the Treatment of Patients with Brain Metastasis (RTOG 79-16). Int J Radiat Oncol Biol Phys, 20:53-58, 1991. |
7916 |
sens |
|
| CNS/mets |
|
Phillips , T., Scott, C., Leibel, S., Rotman, M. and Weigensberg, I.: Results of a Randomized Comparison of Radiotherapy and Bromodeoxyuridine to Radiotherapy Alone for Brain Metastases: Report of RTOG Trial 89-05. Proc Am Soc Thera Radiol Oncol (ASTRO), San Francisco, Int J Radiat Oncol Biol Phys, 30 (Supplement 1):215, [107], 1994. |
8905 |
sens |
|
| CNS/mets |
|
Sause, W., Scott, C., Krisch, B., Rotman, M., Sneed, P., Murray, K., Davis, L., Curran, W., Choi, K., Selim, H., Mohiuddin, M. and Grigsby, P.: RTOG 85-28 - Accelerated Fractionation in Treatment of Patients with Supratentorial Brain Metastases. Proc American Radium Society, Montreal, 10-11, [25], 1991. |
8528 |
td |
|
| CNS/other |
|
Schultz, C., Scott, C., Wasserman, T., Fisher, B., Abrams, R., Sherman, W., Fetell, M. and Nelson, J.: Pre-Irradiation Chemotherapy (CTX) with Cytoxan, Adriamycin, Vincristine, and Decadron (CHOD) for Primary Central Nervous System Lymphomas (PCNSL): Initial Report of Radiation Therapy Oncology Group (RTOG) Protocol 88-06. Proc Am Soc Clin Oncol (ASCO), Dallas, Texas, Proc Am Soc Clin Oncol, 13 (March):174, [485], 1994. |
8806 |
chemo |
|
| CNS/other |
|
Kun, L., Burger, P., Kovnar, E., Rekate, H., Shuster, J. and Leibel, S.: Childhood Intracranial Ependymomas - Prospective Study of Surgery and Radiation Therapy (RT). Eleventh International Conference on Brain Tumor Research and Therapy, Napa, California, Proceeding Book, [29], 1995. |
8532 |
surg |
|
| CNS/other |
|
Nelson, D., Martz, K., Bonner, H., Nelson, J., Newall, J., Kerman, H., Thomson, J. and Murray, K.: Non-Hodgkin's Lymphoma of the Brain: Can High Dose, Large Volume Radiation Therapy Improve Survival? Report on a Prospective Trial by the Radiation Therapy Oncology Group (RTOG): RTOG 83-15. Int J Radiat Oncol Biol Phys, 23(1):9-17, 1992. |
8315 |
td |
|
| CNS/other |
|
Schultz, C., Scott, C., Sherman, W., Donahue, B., Fields, J., Murray, K., Fisher, B., Abrams, R. and Mies-Kindblom, J.: Pre-Irradiation Chemotherapy (CTX) with Cytoxan, Adriamycin, Vincristine, and Decadron (CHOD) for Primary Central Nervous System Lymphomas (PCNSL): Initial Report of Radiation Therapy Oncology Group (RTOG) Protocol 88-06. 11th International Conference on Brain Tumor Research and Therapy, Napa, California, Proceedings Book, [48], 1995. |
8806 |
chemo |
|
| CNS/primary |
|
Simpson, J., Horton, J., Scott, C., Curran, W., Rubin, P., Fischbach, J., Isaacson, S., Rotman, M., Asbell, S., Nelson, J. and Weinstein, A.: Influence of Location and Extent of Surgical Resection on Survival of Patients with Glioblastoma Multiforme: Results of 3 Consecutive RTOG Trials. Proc Am Soc Thera Radiol Oncol (ASTRO), San Diego, Int J Radiat Oncol Biol Phys, 24 145, [36], 1992. |
7401, 7918, 8302 |
surg |
|
| CNS/primary |
|
Fischbach, A., Martz, K., Nelson, J., Griffin, T., Chang, C., Horton, J. and Nelson, D.: Long-Term Survival in Treated Anaplastic Astrocytomas. A Report of Combined RTOG/ECOG Studies. Am J Clin Oncol (CCT), 14(5):365-370, 1991. |
7401, 7918 |
chemo |
|
| CNS/primary |
|
Curran, W., Scott, C., Horton, J., Nelson, J., Weinstein, A., Nelson, D., Fischbach, A., Chang, C., Rotman, M., Asbell, S. and Powlis, W.: Does the Extent of Surgery Influence Outcome for Astrocytoma with Atypical or Anaplastic Foci (AAF)? A Report From Three Radiation Therapy Oncology Group (RTOG) Trials. ANA, Ann Neuro, 30 (2):308, [p288], 1991. |
|
path |
| CNS/primary |
|
Meis, J., Martz, K. and Nelson, J.: Mixed Glioblastoma Multiforme and Sarcoma: A Clinicopathologic Study of 26 RTOG Cases. Cancer, 67:2342-2349, 1991. |
|
path |
|
| CNS/primary |
|
Curran, W., Scott, C., Nelson, J., Weinstein, A., Phillips, T., Murray, K., Fischbach, A., Yakar, D., Schwade, J., Powlis, W. and Nelson, D.: A Randomized Trial of Accelerated Hyperfractionated Radiation Therapy and Bis-Chlorethyl Nitrosourea for Malignant Glioma: A Preliminary Report of Radiation Therapy Oncology Group 83-02. Cancer, 70(12):2909-2917, 1992. |
8302 |
td/chemo |
|
| CNS/primary |
|
Curran, W., Scott, C., Nelson, J., Martin, L., Weinstein, A., Phillips, T., Murray, K., Fischbach, A., Yakar, D., Schwade, J., Corn, B. and Nelson, D.: Survival Comparison of Radiosurgery Eligible and Ineligible Malignant Glioma Patients Treated with HFX RT and BCNU: A Report of RTOG 83-02. Proc Am Soc Thera Radiol Oncol (ASTRO), San Diego, Int J Radiat Oncol Biol Phys, 24 (1):129-130, [12], 1992. |
8302 |
SRS |
|
| CNS/primary |
|
Scott, C., Pajak, T. and Curran, W.: Nonparametric Survival Regression Trees and Application to Three Radiation Therapy Oncology Group (RTOG) Malignant Glioma Trials. Society for Clinical Trials, Philadelphia, Control Clin Trials DMA, 13 (5):383, [A16], 1992. |
7401, 7918, 8302 |
stat |
|
CNS/primary
/brain |
|
Fulton, D., Urtasun, R., Farnan, N., DelRowe, J., Kinsella, T. and Lester, S.: Survival Improvement in Anaplastic Astrocytoma, Combining External Radiation with Halogenated Pyrimidines. Final Report of RTOG 86-12, Phase I-II Study. 11th International Conference on Brain Tumor Research, Napa, California, [20], 1995. |
8612 |
BRM |
|
CNS/primary
/brain |
|
Donahue, B., Scott, C., Nelson, J., Rotman, M., Murray, K., Nelson, D., Banker, F., Earle, J., Fischbach, J., Asbell, S., Gaspar, L., Markoe, A. and Curran, W.: Influence of an Oligodendrogliomal Component on the Survival of Patients with Anaplastic Astrocytomas: A Report of Radiation Therapy Oncology Group 83-02. Proc Am Soc Thera Radiol Oncol (ASTRO), Los Angeles, CA, Int J Radiat Oncol Biol Phys, 36 (1):161, [5], 1996. |
8302 |
path |
|
CNS/primary
/brain |
|
Curran, W. J., Scott, C. B., Yung, W. A., Scarantino, C., Urtasun, R., Movsas, B., Jones, C., Simpson, J., Fischbach, A., Petito, C. and Nelson, J.: Imaging Response is Highly Predictive of Survival of Malignant Glioma Patients Treated with Standard or Hyperfractionated RT and Carmustine in RTOG 90-06. Proc Am Soc Thera Radiol Oncol (ASTRO), Los Angeles, CA, Int J Radiat Oncol Biol Phys, 36 (1):160, [3], 1996. |
9006 |
td/chemo |
|
CNS/primary
/brain |
|
Yousem, D., Corn, B., Scott, C., Rotman, M., Asbell, S., Nelson, D., Martin, L. and Curran, W.: White Matter Changes are Significantly Correlated with RT Dose: Observations From a Randomized Dose Escalation Trial for Malignant Glioma (RTOG 83-02). Proc Am Soc Thera Radiol Oncol (ASTRO), New Orleans, LA, Int J Radiat Oncol Biol Phys, 27 206-107, [129], 1993. |
8302 |
lateff |
|
CNS/primary
/brain |
|
Werner-Wasik, M., Scott, C. B., Nelson, D. F., Gaspar, L. E., Murray, K. J., Fishbach, J. A., Nelson, J. S., Weinstein, A. S. and Curran, W. J.: Final Report of a Phase I/II Trial of Hyperfractionated and Accelerated Hyperfractionated Radiation Therapy with Carmustine for Adults with Supratentorial Malignant Gliomas: RTOG 83-02. Cancer, 77(8):1535-1543, 1996. |
8302 |
td/chemo |
|
CNS/primary
/brain |
|
Urtasun, R., Kinsella, T., Farnan, N., DelRowe, J., Lester, S. and Fulton, D.: Survival Improvement in Anaplastic Astrocytoma, Combining External Beam Radiation with Halogenated Pyrimidines: Final Report of RTOG 86-12, Phase I-II Study. Int J Radiat Oncol Biol Phys, 36(5):1163-1167, 1996. |
8612 |
sens |
|
CNS/primary
/brain |
|
Choucair, A. K., Scott, C., Urtasun, R., Nelson, D., Coia, L. and Curran, W.: Neuropsychological Evaluation (NPE) and Quality of Life (QOL) in Patients with Malignant Gliomas (MG). RTOG 91-14. Eleventh International Conference on Brain Tumor Research and Therapy, Silverado, Napa, California, Proceedings Book, [18], 1995. |
9114 |
QOL |
|
CNS/primary
/brain |
|
Scott, C. B., Nelson, J. S., Farnan, N. C., Curran, W. J., Murray, K. J., Fischbach, J., Gaspar, L. E. and Nelson, D. F.: Central Pathology Review in Clinical Trials for Patients with Malignant Gliomas: A Report of Radiation Therapy Oncology Group 83-02. Cancer, 76(2):307-313, 1995. |
8302 |
path |
|
CNS/primary
/brain |
|
Scott, C.: Quality-Adjusted Survival of Malignant Glioma Patients. American Statistical Association - 155th Annual Meeting, Orlando, Florida, Summaries of Papers Presented at the Joint Statistical Meetings, 4, 1995. |
8302 |
QOL/stat |
|
CNS/primary
/brain |
|
